Rehabilitation of COVID-19 Patients with Cognitive, Autonomic and Insomnia Disorders Using Medicinal Leech Therapy

Serikbayeva Saltanat, Namazbay ORMANOV, Talgat ORMANOV, Ibragim Ishigov, Murat Zhunussov, Gulnaz KAYSHİBAYEVA, Ferruh Yücel

2023

Closed access Metadata (CSL-JSON)
DOI 10.53445/batd.1277497
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

New coronaNew coronavirus disease (COVID-19) pandemic is a historical and urgent issue worldwide. The long-term consequences of the disease are neurological disorders, which need further investigation in terms of treatment and prevention. Apart from the traditional medical approach, management of cognitive, autonomic and sleep complications may be rehabilitated using medicinal leeches. The purpose of this study is to compare the neurological condition of COVID-19 patients before and after hirudotherapy. This cross-sectional study was conducted from January to December 2021 at the medical centre of the Khoja Akhmet Yassawi International Kazakh-Turkish University. The research population consisted of 83 patients with mild and severe forms of COVID-19 (more than 6 months), who underwent medicinal leech therapy (MLT). MLT was applied to the patients on the 6th and 11th days and their assessment of cognitive, autonomic and sleep disorders were carried out. Statistical analysis was carried out using SPSS Statistics (version 20.0, IBM, USA). The results of studies indicate a progressive neurological deterioration in COVID-19 patients. Neuropsychological observations in patients taking a full course of MLT showed an objective improvement in their cognitive, autonomic and sleep disorders. In particular, the Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), Montreal Cognitive Assessment (MoCA) Scale, Schulte Tables, Spielberger-Khanin Anxiety Scale (SKAS), Beck depression inventory (BDI), Study scheme to identify signs of autonomic disorders, Epworth Sleepiness Scale (ESS), Index of Severity of Sleep Disorders (ISSD) values improved after the MLT procedures.